• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Calidi Biotherapeutics, Inc. Common Stock (NY:CLDI)

0.1750 +0.0060 (+3.55%)
Official Closing Price Updated: 8:00 PM EDT, Jun 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,577,037
Open 0.1710
Bid (Size) 0.1615 (100)
Ask (Size) 0.1750 (5,000)
Prev. Close 0.1690
Today's Range 0.1621 - 0.1767
52wk Range 0.1577 - 19.20
Shares Outstanding 7,167,721
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on June 9
June 05, 2026
Via ACCESS Newswire
New Pill Offers Hope Against Pancreatic Cancer
June 03, 2026
Via Investor Brand Network

Performance

YTD
-85.2%
-85.2%
1 Month
-11.8%
-11.8%
3 Month
-52.1%
-52.1%
6 Month
-88.1%
-88.1%
1 Year
-95.6%
-95.6%

More News

Read More
New Inhalable Agent Could Improve Treatment Outcomes in Lung Cancer
June 02, 2026
Via Investor Brand Network
Scientists Inch Closer to Developing a Lung Cancer Blood Test
May 21, 2026
Via Investor Brand Network
Researchers Create Less Toxic, More Effective Immunotherapy Against Blood Cancer
May 20, 2026
Via Investor Brand Network
NHS Starts Offering Immunotherapy Injection to Cancer Patients
May 12, 2026
Via Investor Brand Network
Study Suggests Timing of Immunotherapy Could Impact Clinical Outcomes
May 11, 2026
Via Investor Brand Network
Study Finds That Vitamin D Supercharges Chemotherapy Against Breast Cancer
May 04, 2026
Via Investor Brand Network
Study Uncovers Why the Risk of Breast Cancer Increases with Age
May 01, 2026
Via Investor Brand Network
Get insights into the top gainers and losers of Thursday's after-hours session. ↗
April 30, 2026
Via Chartmill
On Wednesday, there are stocks with unusual volume. Let's take a look. ↗
April 29, 2026
Via Chartmill
Curious about the most active stocks on Tuesday? ↗
April 28, 2026
Via Chartmill
Early Trial Suggests mRNA Vaccine Could Be Effective Against Pancreatic Cancer
April 22, 2026
Via Investor Brand Network
News headline image
RedChip's Biotech Virtual Investor Conference Replays Now Available
April 21, 2026
Via ACCESS Newswire
New AI Tool Could Boost the Early Detection of Lung Cancer
April 16, 2026
Via Investor Brand Network
Topics Artificial Intelligence
New Urine Test Boosts Forecasting of Treatment Outcomes in Bladder Cancer
April 13, 2026
Via Investor Brand Network
Immunotherapy Could Be Boosted by Blocking the Removal of Cancer RNA
April 10, 2026
Via Investor Brand Network
News headline image
RedChip's April 16 Virtual Investor Conference to Feature Companies Advancing Clinical Pipelines and Scalable Healthcare Platforms
April 07, 2026
Via ACCESS Newswire
Report Forecasts the Cancer Immunotherapy Market Hitting $311.4B by 2031
April 02, 2026
Via Investor Brand Network
Research Suggests the Thymus is Critical in Immunotherapy Outcomes
March 30, 2026
Via Investor Brand Network
Topics Artificial Intelligence
Major Discovery Could Reshape Cancer Immunotherapy
March 27, 2026
Via Investor Brand Network
Oncolytic Virus Therapy is Set to Transform Cancer Care
March 20, 2026
Via Investor Brand Network
Scientists Discover Why Colon Cancer Diagnoses are Increasing in Young Adults
March 18, 2026
Via Investor Brand Network
Microbial Ecosystems Play a Big Role in the Efficacy of Cancer Immunotherapy
March 13, 2026
Via Investor Brand Network
Unusual volume stocks in Tuesday's session ↗
March 10, 2026
Via Chartmill

Frequently Asked Questions

Is Calidi Biotherapeutics, Inc. Common Stock publicly traded?
Yes, Calidi Biotherapeutics, Inc. Common Stock is publicly traded.
What exchange does Calidi Biotherapeutics, Inc. Common Stock trade on?
Calidi Biotherapeutics, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Calidi Biotherapeutics, Inc. Common Stock?
The ticker symbol for Calidi Biotherapeutics, Inc. Common Stock is CLDI on the New York Stock Exchange
What is the current price of Calidi Biotherapeutics, Inc. Common Stock?
The current price of Calidi Biotherapeutics, Inc. Common Stock is 0.1750
When was Calidi Biotherapeutics, Inc. Common Stock last traded?
The last trade of Calidi Biotherapeutics, Inc. Common Stock was at 06/08/26 08:00 PM ET
What is the market capitalization of Calidi Biotherapeutics, Inc. Common Stock?
The market capitalization of Calidi Biotherapeutics, Inc. Common Stock is 1.25M
How many shares of Calidi Biotherapeutics, Inc. Common Stock are outstanding?
Calidi Biotherapeutics, Inc. Common Stock has 1M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap